Fig. 6From: Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistanceCurrent TB diagnostic pathway (left) and potential diagnostic pathways to optimise rapid diagnosis (right) including WGS and additional molecular testing if resources allowBack to article page